Cystine Capacity Clinical Study (CysCap)

Completed

Conditions studied: Cystinuria

In brief

The purpose of this study is to determine whether urinary cystine capacity, an assay used to measure the amount of cystine in the urine, can be used to predict stone recurrence in patients with cystinuria.

Key facts

Study ID

NCT02120105

Run by

NYU Langone Health

People needed

30

Starts

2012-09-01

Expected to finish

2017-02-24

Last updated by the study team

2018-12-03

Who can join

Age: 8 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a confirmed laboratory diagnosis of cystinuria will be included in this study. There will be no age barrier to inclusion, but included patients must be able to reliably collect urine for 24 hours. Men and women will be recruited equally and there are no restrictions for racial or ethnic origin in this study.
• Patient enrollment will require signing of an informed consent document approved by the Lenox Hill IRB.
• For children 8-18 years of age, signing an assent to participate will also be required.

You may not qualify if…

• Patients will be excluded if they cannot sign consent or assent.
• Furthermore if the patient cannot reliably collect urine for 24 hours or adhere to study follow up visit requirements.

Where it is running

• NYU Langone Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.